Therapeutic Drug Monitoring of Intravenous Busulfan and Analytical Challenges due to the Drug Formulation Excipient PEG 400: Letter to the Editor.

Authors :: Vethe NT
Andersen AM
Gedde-Dahl T
Büchner J
Bergan S
Source :: Therapeutic drug monitoring [Ther Drug Monit] 2024 Jun 01; Vol. 46 (3), pp. 416-417. Date of Electronic Publication: 2024 Apr 16.
Publication Year :: 2024
Abstract: Competing Interests: The authors declare no conflict of interest.

Subjects :: Humans
Administration, Intravenous
Drug Monitoring methods
Busulfan pharmacokinetics
Busulfan administration & dosage
Busulfan blood
Polyethylene Glycols
Excipients

Full Text Access

Tools